Bank of Montreal
COGT icon

Bank of Montreal’s Cogent Biosciences COGT Stock Holding History

Bank of Montreal’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33M Buy
86,164
+47,855
+125% +$1.67M ﹤0.01% 1518
2026
Q1 		$1.47M Buy
38,309
+28,417
+287% +$1.05M ﹤0.01% 1825
2025
Q4 		$351K Sell
9,892
-13,632
-58% -$383K ﹤0.01% 2493
2025
Q3 		$338K Buy
+23,524
New +$279K ﹤0.01% 2472
2025
Q2 		– Sell
-205,030
Closed -$1.23M – 3549
2025
Q1 		$1.23M Buy
+205,030
New +$1.61M ﹤0.01% 1722
2024
Q4 		– Sell
-287,610
Closed -$3.13M – 3568
2024
Q3 		$3.13M Buy
+287,610
New +$2.8M ﹤0.01% 1500
2021
Q4 		– Sell
-131,757
Closed -$1.16M – 3545
2021
Q3 		$1.16M Buy
+131,757
New +$1.01M ﹤0.01% 2392
2019
Q3 		– Sell
-11
Closed – – 4748
2019
Q2 		$0 Buy
11
+10
+1,000% +$133 ﹤0.01% 4880
2019
Q1 		$0 Sell
1
-66
-99% -$1.13K ﹤0.01% 4378
2018
Q4 		$1K Buy
67
+61
+1,017% +$1.8K ﹤0.01% 4512
2018
Q3 		$0 Hold
6
– – ﹤0.01% 4741
2018
Q2 		$0 Buy
+6
New +$288 ﹤0.01% 4732

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of Montreal's COGT Position: Q2 2026 in Review

Bank of Montreal increased its Cogent Biosciences (COGT) stake by 125% in Q2 2026, buying an estimated $1.67M and bringing the position to 86,164 shares worth $3.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1518.

Bank of Montreal first reported a position in COGT in Q2 2018 and has held it in 12 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Bank of Montreal held 86,164 shares of Cogent Biosciences worth $3.33M as of Q2 2026.
  • Bank of Montreal bought 47,855 Cogent Biosciences shares in Q2 2026, an estimated $1.67M.
  • Cogent Biosciences made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1518 holding.
  • Bank of Montreal first reported a position in Cogent Biosciences in Q2 2018 and has held it in 12 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.